Antibody responsive malignanacy
Drug safety update
December 2014: Rituximab: progressive multifocal leukoencephalopathy in a patient
December 2014: Rituximab: screen for hepatitis B virus before treatment
Nice guidance (also see drug specific guidance below)
Rituximab causes the lysis of B lymphocytes and may be used to treat rheumatoid arthritis when therapy with other DMARDs including one anti-TNF has been inadequate or not tolerated.
Pack | Price |
---|---|
2 vial | £349.25 |
Pack | Price |
---|---|
1 vial | £873.15 |